Remove Clinical Trials Remove Drugs Remove Pharma Companies Remove Pharma Production
article thumbnail

Pharma websites need disruption

World of DTC Marketing

Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. ROI drives pharma companies. In the past, pharma product websites had a huge effect on whether a patient asks for an Rx. 5ive: It’s time to update clinical trial information. Want proof?

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.

article thumbnail

Ep. 006 – Mark Stinson & Bob Baurys Podcast Transcript

Pharma Marketing Network

Mark (83Bar): Yea and I was almost in service to clinics like Bob’s. My background for decades now is in the pharma marketing and branding space, working with all sorts of pharma products, devices, diagnostics. Do you connect patients with the clinical trial folks? Mark (83Bar): So that’s the challenge.

Doctor 40
article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.